Diagnosis and Treatment of Primary Diffuse-Type Tenosynovial Giant Cell Tumors of the Cervical Spine
Wang Kai,Liu Xiaoguang,Liu Zhongjun,Yu Miao
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20132556
IF: 6.133
2014-01-01
Chinese Medical Journal
Abstract:Diffuse-type tenosynovial giant cell tumor (D-TGCT) belongs to a group of lesions believed to arise from tendon sheaths, bursae, or the synovium of diarthrodial joints. The etiology of D-TGCT is unknown. Because it shares histological characteristics with pigmented villonodular synovitis, however, D-TGCT is also termed extra-articular pigmented villonodular synovitis. D-TGCT, which occurs mainly in middle-aged women (20-50 years of age1), usually involves large load-bearing joints (e.g., knee, ankle, and hip). Clinical case reports of D-TGCT involving the spine are rare.2 We retrospectively analyzed a series of three patients diagnosed with cervical D-TGCT in our department over a 10-year period. Between April 2002 and April 2012, three D-TGCT patients exhibited cervical accessory destruction and were hospitalized in our department. These three patients were women aged between 23 and 44 years. None had a history of tumor site surgery or radiation therapy. The patients presented with different degrees of preoperative neck discomfort or pain. One patient had symptoms of neurological injury. In all three cases, the lesion was located at the cervical spine: two upper cervical lesions and one that had invaded the lower cervical spine. The latter patient had osteolytic bone destruction in the corresponding vertebral body and accessories. Two cases involved two adjacent segments, and one case involved more than two segments. Preoperative computed tomography (CT) showed that the lesions were characterized by soft-tissue density with CT values of approximately 30-60 HU. The chief features were accessory-centric, expansile, osteolytic bone destruction and incomplete or thinning cortical bone. In some cases, the lesion invaded the spinal canal, creating pressure on the dural sac and spinal cord. Magnetic resonance imaging (MRI) clearly showed diffuse lesion infiltration into surrounding tissues and some lobulated tumors. Two cases were characterized by short T1-weighted signals and long T2-weighted signals. In one case, there was isointensity on T1-weighted signals and long T2-weighted signals. Enhanced scanning of that lesion showed moderate enhancement. All patients underwent preoperative CTguided biopsy, with the pathological specimen processed for histological and immunohistochemical analysis. Two cases were confirmed as D-TGCT by the preoperative pathological diagnosis, and one was preoperatively (inconclusively) diagnosed as fibrous histiocytoma, which was later confirmed as D-TGCT by postoperative pathological diagnosis. Each patient underwent one-stage combined anteroposterior tumor resection. Two patients experienced piecemeal resection, and one underwent en bloc resection. The operative time was 300-447 minutes (average 389 minutes). The intraoperative bleeding volume was 800-1 500 ml (average 1 266 ml). All tumor tissues in the three patients were completely removed. The tumor tissue was yellow or white and toughened, with a surrounding capsule. It had invaded tissues around it. Postoperative pathology confirmed that all three patients had D-TGCT (Figure 1).Figure 1.: A 33-year-old woman had experienced neck pain and right hand numbness for 2 years. A and B: Preoperative CT images show left accessory-centric, osteolytic, expansive bone destruction at C6, a soft tissue density shadow distributed in the lesion, and a pressurized and discontinuous shell surrounding the bone. The lesion density is uneven. C-E: MRI images show a tumor with long T1 and short T2 signals mixed with a patchy long T2 signal. This abnormal signal involved the spinal canal and intervertebral foramen, pressing against the dural sac and spinal cord. F: Postoperative lateral images show that the position of the internal fixation was favorable. G: Photomicrograph shows a hypercellular lesion composed of mononuclear cells, xanthoma cells, and osteoclast-like giant cells— consistent with a diagnosis of tenosynovial giant cell tumor (H&E, original magnification ×40).Symptoms of pain and discomfort were alleviated postoperatively. Patient 2 had suffered right hand numbness, which was significantly improved. The mean follow-up period was 6 years (range 1-11 years). No recurrence was noted in any patient at the date of the last follow-up. TGCT, a variety of soft tissue tumor can further be classified as a focal-type tenosynovial giant cell tumor (F-TGCT) or a D-TGCT. F-TGCT primarily occurs in the fingers and has clear boundaries, whereas D-TGCT occurs in large load-bearing joints such as the knee and ankle. It lacks clear boundaries or displays capsular invasion. D-TGCT rarely occurs in the spine, but when it does it is believed to arise from the synovial membrane of the facet joints.3 There is no specific clinical manifestation of the D-TGCT, although it is most often associated with pain and discomfort in the neck or back. In rare cases, there is neurological injury. It also has no specific radiological manifestations. Radiography reveals focal soft-tissue mass shadows in approximately 50% of patients, occasionally accompanied by bone destruction, periosteal reaction, and/or calcification in the lesion. CT imaging can clearly identify the degree and range of bone destruction. MRI often shows a signal that is equal to or higher than that of muscle on T1-weighted imaging (T1WI), whereas the features on T2WI are varied, characterized by a hypointense, isointense, or hyperintense signal.4 The lack of specific MRI features can cause confusion between giant cell tumors of bone and aneurysmal bone cysts. Hence, MRI can be used only as an auxiliary technique for establishing a diagnosis. Histologically, D-TGCT has been characterized by the presence of monocytes and varying amounts of multinucleated giant cells, foam cells, chronic inflammatory cells, and hemosiderin—a picture consistent with our cases. Immunohistochemically, biopsy specimens from all three patients were positive for vimentin and CD68, suggesting that monocytes comprise the majority of reactive cells in D-TGCT, which has proved to be the pathological characteristic of TGCTs. Therefore, histological and immunochemical staining of preoperative CT-guided biopsy specimens is a suitable, accurate method for preoperative diagnosis. Biopsy results are thus useful for choosing the surgical method, determining the extent of surgery, and predicting prognosis. The surgical findings indicated that the tumor tissue had a diffuse, invasive growth pattern, was fused with adjacent normal tissue, and had indistinct borders. These findings supported the preoperative pathological diagnosis. The therapy administered usually depends on the local recurrence rate of a tumor. At present, surgical resection is the preferred treatment option for D-TGCT. Gross total excision can help reduce its recurrence rate.5 One of our patients underwent en bloc tumor excision. The other two had extracapsular dissection and piecemeal resection, respectively. No recurrence was seen during a long-term followup period, suggesting that if onestage en bloc tumor resection cannot be performed complete piecemeal resection can effectively reduce the probability of tumor recurrence. However, one study reported a recurrence rate as high as 18% after the initial gross total excision.5